LAG-3 Antibody (L4-PL33) - BSA Free, Novus Biologicals™

Catalog No.	Quantity
NB259929	100 μg
NB387823	25 ug

Catalog No. NB259929 Supplier Novus Biologicals Supplier No. NBP323442100UG

Description

Mouse Monoclonal Antibody

LAG-3 Monoclonal antibody specifically detects LAG-3 in Human, Primate samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Neutralization

Specifications

• Antigen: LAG-3
• Applications: Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin)
• Classification: Monoclonal
• Clone: L4-PL33
• Concentration: 1 mg/ml
• Conjugate: Unconjugated
• Dilution: Western Blot 5 ug/mL, Flow Cytometry, ELISA, Immunohistochemistry 1:10 - 1:500, Immunocytochemistry/Immunofluorescence 1:10 - 1:500, Immunoprecipitation 10 ug/mL, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen 1:150, Block/Neutralize
• Formulation: PBS, 10% glycerol
• Gene Alias: 17b4, 17b4 lag3, 17b4 neutralizing, anti human lag3, Anti-LAG-3, CD223, CD223 Antigen, Human LAG3, Human LAG-3, LAG3, LAG-3, LAG-3 17b4, LAG-3 blocking, lymphocyte activating 3, lymphocyte activation gene 3 protein, lymphocyte-activation gene 3, Secreted lymphocyte activation gene 3 protein, sLAG-3
• Host Species: Mouse
• Immunogen: This LAG-3 Antibody (L4-PL33) was prepared from synthetic peptide corresponding to 30 aa (GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY) from the first N-terminal D1 domain of human LAG-3 (lymphocyte activation gene-3).
• Purification Method: Protein A or G purified
• Quantity: 100 μg
• Regulatory Status: RUO
• Research Discipline: Adaptive Immunity, Cancer, Immunology, Innate Immunity
• Primary or Secondary: Primary
• Gene ID (Entrez): 3902
• Target Species: Human, Primate
• Content And Storage: Store at 4°C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Form: Purified
• Isotype: IgG1 κ